Conversations on 
Twitter :
- Amid consolidation, are CROs starting to resemble pharmas?
- What should we make of Idenix in the wake of Bristol Myers' hep c failure?
@FierceBiotech: Brain signals when 'Special K' will do the trick. More | Follow @FierceBiotech
@JohnCFierce: Elan now down 12% on bapi fiasco. So does the board have a short list of CEO candidates looking forward to a really tough challenge? | Follow @JohnCFierce
@RyanMFierce: Not much left at biotech Agennix after talactoferrin failure. More | Follow @RyanMFierce
> Amneal Pharmaceuticals plans to pump $120 million into manufacturing, R&D and distribution facilities spread across New York, New Jersey and Kentucky and create more than 500 jobs. Item
> PharmaEngine will pay up to $56 million in milestone fees to Nanobiotix in an alliance to develop NBTXR3, which is in early-stage development for patients with soft tissue sarcoma. Item
> New York biotech startup Innovimmune aims to bypass venture groups and land an early pact with pharma to develop its pre-IND candidates for inflammatory and autoimmune conditions. Article
> The U.S. defense officials ordered Sarepta Therapeutics to halt work on an Ebola treatment because of funding issues. Item
Pharma News
@FiercePharma: Endo Health's Q2 profits nosedive on Lidoderm patent litigation charge. More | Follow @FiercePharma
> War-torn Syrian drug plants shut down, triggering shortages. Article
> Researchers eye biomarkers for safer Cox inhibitor use. Story
> WSJ: Top FDA officials knew about email surveillance. Report
> J&J faces new marketing probes as Risperdal settlement nears. More
@FierceMedDev:The plot thickens in the FDA's surveillance of whistleblowers. More | Follow @FierceMedDev
@MarkHFierce: Check out the latest preclinical breakthrough news at FierceBiotechResearch. | Follow @MarkHFierce
@DamianFierce: Mindray Medical rides across-the-board sales growth to a big Q2. More | Follow @DamianFierce
> Device exec canned over Chick-fil-A outburst. More
> Cochlear profit plummets as firm plans implant relaunch. Story
> Sunshine Heart snags conditional approval for pump. Article
Biotech Research News
> Epilepsy drug boosts brain function in Alzheimer's preclinical tests. News
> HIV viral fragment delivers promising acute liver-failure treatment. Story
> Isis Pharmaceuticals' 'anti-sense' drug combats muscular dystrophy mice. More
> Teva's MLK inhibitor blocks aggressive breast cancer in MSU study. Article
Pharma Manufacturing News
> Manufacturing, pricing problems lead to K-V bankruptcy. Item
> Amneal doubling U.S. capacity, to add 500 jobs. News
> China sweeps in on drug counterfeiters. Report
> Fuji buys DKSH Thailand plant for $53M. News
And Finally… Theratechnologies' hormone drug improved executive function and verbal memory in older patients. Article